InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（22 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
22
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Takeda Pharmaceutical Co Ltd, External Director. Officer active across 6 companies, notably Phathom Pharmaceuticals, Inc.. In total, 31 reports have been logged. Split: 0 buy · 22 sells. Total volume traded: €33.1m. Activity tracked since 3 May 2021. The latest transaction was disclosed on 8 December 2025 (C). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Takeda Pharmaceutical Co Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报31 总计
1,250,000 股0Common StockSEC:0001395064-25-000172:0
6,724,000 股@ US$1.95100.0% 占其流量Common StockSEC:0001395064-25-000140:0
3,703,703 股@ US$8.1081.7% 占其流量Common StockSEC:0001395064-24-000008:0
5,883,500 股0Common StockSEC:0001395064-22-000146:0
5,750,000 股0Common StockSEC:0001395064-22-000121:0
7,359,304 股0Common StockSEC:0001395064-22-000040:0
128,745 股@ US$18.430.22% mcap45.6% 占其流量Common StockSEC:0001395064-21-000248:0
12,517 股@ US$18.470.021% mcap4.4% 占其流量Common StockSEC:0001395064-21-000246:0
57,224 股0Common StockSEC:0001395064-21-000238:0
228,696 股0Common StockSEC:0001395064-21-000231:0
1,475,121 股Common StockSEC:0001395064-21-000216:0
1,615,427 股Common StockSEC:0001395064-21-000203:0
2,609 股@ US$35.050.3% 占其流量Common StockSEC:0001395064-21-000153:0
8,226 股@ US$35.160.8% 占其流量Common StockSEC:0001395064-21-000148:0
22,881 股@ US$35.462.2% 占其流量Common StockSEC:0001395064-21-000142:0
200 股@ US$35.000.0% 占其流量Common StockSEC:0001395064-21-000125:0
9,294 股@ US$35.310.9% 占其流量Common StockSEC:0001395064-21-000121:0
3,305 股@ US$35.080.3% 占其流量Common StockSEC:0001395064-21-000119:0
2,826 股@ US$35.060.3% 占其流量Common StockSEC:0001395064-21-000113:0
1,191 股@ US$35.280.1% 占其流量Common StockSEC:0001395064-21-000111:0
2,264 股@ US$35.050.2% 占其流量Common StockSEC:0001395064-21-000109:0
4,300 股@ US$35.180.4% 占其流量Common StockSEC:0001395064-21-000107:0
4,133 股@ US$35.370.4% 占其流量Common StockSEC:0001395064-21-000105:0
7,469 股@ US$36.450.7% 占其流量Common StockSEC:0001395064-21-000103:0
8,911 股@ US$35.580.8% 占其流量Common StockSEC:0001395064-21-000089:0
31 条申报中的 25 条
About Takeda Pharmaceutical Co Ltd
TAKEDA PHARMACEUTICAL CO LTD is an External Director associated with Phathom Pharmaceuticals, Inc., Day One Biopharmaceuticals, Inc., Ovid Therapeutics Inc., HilleVax, Inc., Xilio Therapeutics, Inc. and Theseus Pharmaceuticals, Inc. The declarant has 31 filings in total, and across the 31 sampled filings from 2021-05-05 to 2025-12-09, sell amounts total 33080776 EUR, with the dominant transaction nature listed as Cession.
